相关实验视频
Updated: Jun 24, 2026

10:09
Inducible T7 RNA Polymerase-mediated Multigene Expression System, pMGX
Published on: June 27, 2017
复杂的多基化物在一种代谢工程的大肠杆菌菌株中的生物合成
B A Pfeifer1, S J Admiraal, H Gramajo
1Department of Chemical Engineering, Stanford University, Stanford, CA 94305-5025, USA.
概括
科学家们对大肠杆菌进行了基因工程设计,以产生6-deoxyerythronolide B (6dEB),这是红色素的核心. 这种工程细菌有效地将酸转化为6dEB,为抗生素生产提供了一个有前途的替代方案.
科学领域:
- 合成生物学 合成生物学
- 生物技术是生物技术.
- 自然产品的合成自然产品的合成
背景情况:
- 抗生素红色素的核心,6-deoxyerythronolide B (6dEB),是一种由Saccharopolyspora erythraea合成的复杂的多基化物.
- 复杂的多基类生物的生产受制于在基因上操纵生产生物的挑战,主要是actinomycetes.
研究的目的:
- 设计一个异质宿主来产生6dEB.
- 为了克服自然聚胺产生的微生物的基因操纵的局限性.
主要方法:
- 对大肠杆菌的衍生物进行基因工程.
- 利用工程化的大肠杆菌作为生物合成的细胞催化剂.
主要成果:
- 工程化的大肠杆菌成功将外源酸转化为6dEB.
- 工程化大肠杆菌催化剂的特异性生产率与高度优化的S. erythraea.工业菌株相当.
结论:
- 大肠杆菌可以被设计成一种可行的宿主,用于生产像6dEB.EB.这样的复杂多基基菌.
- 这种方法为有价值的自然产品的生物合成提供了强大的替代方案,绕过了本地生产者的局限性.
相关概念视频
Amino Acid Catabolism
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

